August 24, 2020

Antidiabetic drugs may have a role in guarding organs affected by COVID-19, researchers say, with trials now underway to confirm it.

"Because it's a viral disease, we see a lot of emphasis on antiviral therapies. But it's also a systemic disease—in fact, a cardiometabolic disease," said Dr. Mikhail Kosiborod, cardiologist at Saint Luke's Mid America Heart Institute and Vice President of research at Saint Luke's Health System.

Read the full Medpage Today article: Diabetes drugs looking for broad role in COVID-19

Related Content

Healio: DARE-19: Dapagliflozin could target key mechanisms activated in COVID-19
As the entire world comes together to attempt to find a vaccine and treatments for this global pandemic, it is exciting that an international trial of this nature was created and is being led by doctors and researchers here in
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
As the entire world comes together to attempt to find a vaccine and treatments for this global pandemic, it is exciting that an international trial of this nature was created and is being led by doctors and researchers here in Kansas City.
blood glucose testing paper with a stethoscope and a heart shape bowl with healthy foods to fight diabetes
Saint Luke’s Mid America Heart Institute Announces Launch of National Cardiometabolic Center Alliance
Alliance to establish Cardiometabolic Centers of Excellence across the nation.